This document is made available in accordance with publisher policies. Please cite only the published version using the reference above. Full terms of use are available: http://www.bristol.ac.uk/pure/about/ebr-terms Abstract The high regioselectivity associated with the Ir-catalyzed borylation of pyridones has been exploited to provide a very direct and efficient entry to C(10) doubly substituted CC4 variants of cytisine. Two approaches have been evaluated based on (i) C-H activation of cytisine (or an N-substituted derivative) followed by N-alkylation (to enable dimer formation) and (ii) direct C-H activation and borylation of CC4 itself. Both approaches provide access to C(10)-functionalized CC4 derivatives, but direct borylation of CC4 allows for a wider range of functional group interconversions to be tolerated.
Pyridones, which offer a predictable but constrained selectivity for electrophilic substitution at C(3) and C(5), have added complexity: two potential metal binding sites associated with the substrate. In earlier work, Hirano and Miura 5 exploited an N-pyridyl moiety as a directing function (to functionalize at C(6)) but otherwise access to pyridone-based boronic esters relies on electrophilic halogenation as a key step. 6 As a consequence, direct C-H functionalization offers an opportunity to extend significantly the range of pyridone substitution patterns available.
We had carried out broadly the same study of both simple and more complex 2-pyridones to determine basic reactivity patterns as described by Hirano and Miura. 4 Our results paralleled those reported earlier although we assessed product distribution (and reaction efficiency) following in situ bromination 7 of the initial Bpin ester to give bromopyridones 2-5 (Scheme 1, Table 1 ). There were, however, differences in terms of the approach we have used which we note here. In our hands, for example, the parent 2-pyridone 1a was unreactive 8 towards C-H activation; we observed no conversion under our standard conditions where we used dtbpy as the bipyridyl ligand. More generally, and based on our experience with related substrates, the presence of an acidic NH (as in 1a) inhibits Ir-catalyzed borylation.
Scheme 1 Ir-Catalyzed borylation/in situ bromination 7 of simple 2-pyridones. Isolated yields [b] 1a R = H 0% 1e R = Boc 0% [c] No conversion observed [a] Product ratios, following in situ bromination 7 were based on 1 H NMR; see text and Supporting Information. [b] Monobromo isomers 2 and 3 were inseparable by chromatography and the combined yield is shown. [c] see text. 8, 9 Within the simple pyridone series shown in Scheme 1, some level of double C-H activation was also observed (via dibrominated products 4 and 5) but consistently C(5) substitution (3 + 5) was preferred over C(4) (2 + 4). Double insertion observed was a result of C-H activation/borylation rather than an additional bromination occurring in step 2 (Scheme 1) 9 and the proportion of dibrominated adducts observed appears to link to the size of the N-substituent (compare products from 1b vs. 1c vs. 1d). Interestingly, the N-benzyl variant 1d gave only pyridone substitution with no indication that borylation of the N-benzyl residue was competitive; however, see below. The N-Boc variant 1e failed to react but the issue here was that rapid N-Boc cleavage occurred under the reaction conditions (based on 1 H NMR analysis) releasing the unreactive parent 2-pyridone 1a.
Our primary interest in this area has, however, been on the application of this C-H activation process to the development of novel heterocyclic ligands that are specific for the 42 nicotinic acetylcholine receptor (nAChR). 10 This subtype is the high affinity nicotine receptor and, with smoking responsible for some 7 million deaths annually (with an associated huge social burden in terms of healthcare expenditure and lost productivity 11 ), is a target of interest for treating tobacco addiction. The pyridonebased cytisine (Tabex ® ) 6a 12 , as well as the structurally related varenicline (Chantix ® ) 13 , target the 42 nAChR providing the basis of a smoking cessation therapy. In their 2017 paper, 4 Hirano and Miura described the borylation of N-Boc cytisine 6e (see below), and here we wish to report our independent work in this area and an extension to more complex cytisine-based ligands.
We have evaluated (-)-cytisine 6a as well as a series of derivatives, including N-Boc cytisine 6e and CC4 7, as substrates for Ir-catalyzed borylation with the objective of gaining access to C(10). CC4 7 is a cytisine-based dimer ligand where the ability to access C(10) was of particular interest given this ligand's nicotinic profile. In 2013 Gotti and Sparatore reported CC4 7 as a partial agonist for both the 42 and 62 nAChR subtypes and suggested an improved profile for smoking cessation due to the great selectivity displayed by CC4 for 2-containing nAChR subtypes. 14 Our hypothesis, based on crystallographic data based on cytisine and varenicline bound to acetylcholine binding protein (AChBP) 15 , was that substitution at C(10) provides an opportunity to interact with the variable (complementary) region of the nAChR, which is associated with subtype differentiation. 16 Previous work by Kozikowski and Kellar, as well ourselves, had generated C(10)-substituted variants of cytisine. 17 However, these involved lengthy synthetic sequences that limited the range of variation that was accessible. Further, this earlier work gave racemic products, which is problematic especially when contemplating construction of dimeric ligands based on CC4.
In this paper, we have evaluated two approaches to the synthesis of C(10) modified variants of CC4 7: (i) C-H activation of cytisine to enable access to a C(10)-modified "monomer" unit (e.g. bromide 9), dimer formation (via N-alkylation) ) followed by further elaboration; and (ii) direct and double C-H activation at C(10) of CC4 7, followed by further functional group manipulation.
The first approach required C-H activation of (-)-cytisine 6a, itself an effective substrate for Ir-catalyzed borylation (Scheme 2). Complete conversion (as judged by 1 H NMR) did require an excess (1.5 equivalents) of B2pin2, however, isolation and purification of the product C(10) boronate ester 8a proved problematic. N-Methyl cytisine 6b is also an efficient substrate, however, N-benzyl cytisine 6c and N-Cbz cytisine 6d showed competing borylation within the aryl moiety of the N-protecting group; it is interesting to compare this to the reactivity of pyridone 1d. Further details of this study, including optimization of key reaction parameters, are available in the Supporting Information.
Scheme 2 Site selective Ir-catalyzed borylation of (-)-cytisine 6a, N-substituted cytisine derivatives 6b-d, and N-Boc cytisine 6e.
In common with Hirano and Miura, we observed very efficient Ir-catalyzed borylation of N-Boc cytisine 6e (Scheme 2). In our hands, and using dtbpy as the preferred ligand in combination with 0.7 equivalents of B2pin2, we achieved essentially quantitative borylation of 6e to give 8e. This was completely selective for C(10) and was readily scaled (to 5 grams, 17 mmol of 6e). This result compares to 77% yield (on a 0.2 mmol scale, but using a different pyridyl ligand) reported earlier. 4 Isolation of (crude) 8e was straightforward with no requirement for any further purification in terms of the use of this Bpin intermediate in subsequent manipulations.
Boronate 8e was converted efficiently to 10-bromocytisine 9 (with concomitant N-Boc cleavage occurring under the Cumediated conditions used) and dimer formation using 1,2-dibromoethane provided the CC4-based bisbromide 10 in good (70%) overall yield (Scheme 3). Ir-catalyzed borylation of CC4 7, so double C-H activation at C(10), offers the advantage of more direct access to bisbromide 10 and this proceeds smoothly (Scheme 4). Table 2 ). Pd(0) catalyzed C-C bond formation provides the bis(cyano), bis(methyl) 18 and the Suzuki cross coupled products 12a-c. respectively. Transformations of bromide 10 also encompassed amidation (to give 12d) and amination (to give 12e and 12f), as well as carbonylation (to give 12g) and Heck coupling (to give 12h) reactions. We have evaluated use of Cu(I)-based amidation (to prepare 12d) but reaction of bisbromide 10 with acetamide and CuI (with TMEDA) led to the formation of an insoluble solid suggestive of a complex being formed between 10 and Cu(I).
The use of bisboronate 11 to access C(10)-functionalised CC4 derivatives was exemplified by direct oxidation of 11, leading to the bishydroxy ligand 12i in 54% yield. Further studies in this area are underway but bisboroate ester 11 has been successfully used in Suzuki cross couplings reactions involving aryl halides.
In summary, and with full acknowledgement to the recent work of Hirano and Miura, 4 we have also successfully applied iridiumcatalyzed borylation to 2-pyridones, with our focus around biologically important substrates exemplified by cytisine 6a and CC4 7. Pyridones are generally excellent substrates for this mode of C-H activation although our experience is that NH pyridones (as in 1a) are less effective. In addition, the presence of a basic (amine) center (as in 6a and 7) does tend to require an excess of B2pin2 for complete conversion. Nevertheless, and given exceptionally clean conversions, product isolation is straightforward and the crude boronate esters (e.g. 11) are very effective as substrates for downstream functionalisation. Details of receptor binding studies (including nicotinic subtype selectivities) and full agonist functional characteristics of the novel CC4 ligands described here will be reported in due course.
The experimental section has no title; please leave this line here.
All reagents were purchased from commercial suppliers and used without further purification unless otherwise stated. Anhydrous solvents were obtained by distillation using standard procedures or by using the Anhydrous Engineering Ltd. double alumina and alumina-copper catalyzed drying columns. Reactions requiring anhydrous conditions were run under an atmosphere of dry nitrogen; glassware and needles were flamed-dried prior to use or placed in the oven (150 °C) for at least 2 h and allowed to cool either in a desiccator, under vacuum, or an atmosphere of nitrogen. Thin layer chromatography was performed using aluminium backed 60 F254 silica plates. Visualisation was achieved by UV fluorescence or a basic KMnO4 or ninhydrin solution and heat. Flash column chromatography was performed on silica gel (Aldrich 40-63 µm, 230-400 mesh) and reverse phase chromatography was performed on an automated Biotage Isolera TM Spektra Four using gradient elution on pre-packed Biotage ® C18 columns. Infrared spectra were recorded using a Perkin Elmer Spectrum One FT-IR Spectrometer as solids or neat films in the range of 600-4000 cm -1 . NMR spectra were recorded using either a Varian 400 MHz or 500 MHz, or JEOL ECP 400 MHz spectrometer. Chemical shifts are quoted in parts per million, coupling constants are given in Hz to the nearest 0.5 Hz. 1 H and 13 C NMR spectra are referenced to the appropriate residual peak. DEPT 135, COSY, HSQC and HMBC were used where necessary in assigning NMR spectra. Melting points were determined using Reichert melting point apparatus. Mass spectra were determined by the University of Bristol mass spectroscopy service by either chemical ionisation (CI + ), electrospray ionization (ESI + ) or electron impact (EI + ) using a Bruker Daltonics Apex IV spectrometer.
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One-pot iridium-catalyzed borylation of 2-pyridones and subsequent bromination; General Procedure 1.
A Schlenk tube was charged with the 2-pyridone substrate (1.0 mmol) [in the case of a liquid substrate, this was added neat after the solvent], [Ir(cod)(OMe)]2 (6.6 mg, 0.01 eq), 4,4'-di-tert-butyl-2,2'-dipyridyl (5.4 mg, 0.02 eq) and bis(pinacolato)diboron (178 mg, 0.70 eq). After purging with nitrogen, deoxygenated and dry THF (1.4 mL) was added and the reaction mixture was heated at reflux for 48 h (in cases where full conversion occurred after 24 h, the reaction was halted at that time). The volatile materials were then removed under reduced pressure and the crude product was dissolved in MeOH (2.5 mL) and a solution of CuBr2 (670 mg, 3.0 mmol) in H2O (2.5 mL) was added. The reaction mixture was heated at 80 °C for 18 h under air, cooled to r.t., diluted with NH4OH (5 mL, 15% aq.) and extracted with DCM (5 x 5 mL).
The combined extracts were dried (MgSO4), filtered and concentrated in vacuo. Purification of the crude reaction mixture by flash column chromatography on silica gel afforded the desired product. Table 1 shows the product distributions of 2-5 but no attempt was made to optimize monosubstitution (vs disubstitution) in the case of 1b or 1c.
Tandem borylation/bromination of 1-methylpyridin-2(1H)-one (1b).
According to General Procedure 1, analysis of the 1 H NMR of the crude reaction mixture showed a conversion of 100%. 
Tandem borylation/bromination reaction of 1-butylpyridin-2(1H)-one (1c).
According to General Procedure 1, analysis of the 1 H NMR of the crude reaction mixture showed a conversion of ≥90%. Products 5-bromo-1- 
Iridium-catalyzed C-H borylation of N-Boc cytisine (6e).
Synthesis of N-Boc 10-(Bpin)cytisine (8e).
A Schlenk tube was charged with N-Boc cytisine (6e) (290 mg, 1.0 mmol), [Ir(cod)(OMe)]2 (6.6 mg, 0.01 eq), 4,4'-di-tert-butyl-2,2'-dipyridyl (5.4 mg, 0.02 eq) and bis(pinacolato)diboron (178 mg, 0.70 eq) and was placed under vacuum and backfilled with nitrogen for three times. THF (1.4 mL) was added and the reaction mixture was heated at reflux for 18 h. The spectroscopic properties of this compound were consistent with the data reported by Hirano and Miura. 4
10-Bromocytisine 9
A Schlenk tube was charged with N-Boc cytisine 6e (2.90 g, 10 mmol), [Ir(cod)(OMe)]2 (66 mg, 1 mol%), 4,4'-di-tert-butyl-2,2'-bispyridine (54 mg, 2 mol%), and bis(pinacolato)diboron (1.78 g, 7.0 mmol). After purging with N2, THF (14 mL) was added and the reaction mixture was heated at reflux for 24 h. The solution was cooled to r.t. and concentrated in vacuo without external heating to give crude 8e, which was used directly in the next step without further purification.
To a solution of crude 8e in MeOH (25 mL), was added a solution of copper(II)bromide (6.70 g, 30 mmol) in water (25 mL). The reaction mixture was stirred at 80 °C for 24 h under air. NH4OH (50 mL, 15% aq. sol.) was added, and the aqueous phase was extracted with DCM (3 × 50 mL). The combined organic phases were concentrated in vacuo andthe residue was distributed between HCl (50 mL, 3 M aq. sol.) and DCM (50 mL). The aqueous phase was washed with DCM (2 × 50 mL), basified with NH4OH (conc.) until pH = 10 and extracted with DCM (5 × 50 mL). The combined organic phases were dried (Na2SO4), filtered, and concentrated in vacuo to give 9 (2.28 g, 85%) as a colourless solid, mp 153 °C (DCMMeOH); Rf = 0.20 (DCM-MeOH, 90:10). The bisboronate 11 (prepared above) was dissolved in MeOH (2.5 mL) and the solution was cooled to 0 °C. A solution of CuBr2 (550 mg, 2.47 mmol) in water (2.5 mL) was added and the reaction mixture was stirred for 48 h under air before being quenched by the addition of NH4OH (15 mL, 15% aq. sol). The aqueous phase was extracted with DCM (3 x 25 mL) and the combined organic layers were dried (MgSO4), filtered and concentrated in vacuo. Purification of the crude product by flash column chromatography afforded bisbromide 10 (185 mg, 79%) as a pale yellow solid; mp 173 °C (DCM-n-Hexane), Rf = 0.31 (DCM-MeOH, 95:5).
[α]D 24 = -108 (c 1.0, MeOH). 
1,2-Bis(10-cyano-N-(-)-cytisinyl)ethane 12a
A Schlenk tube was charged with bromide 10 (169 mg, 0.30 mmol), Pd(PPh3)4 (27 mg, 0.08 eq) and zinc cyanide (42 mg, 1.2 eq), placed under vacuum and backfilled with nitrogen for three times. DMF (1 mL, 0.8 M) was added, and the reaction mixture was stirred at 80 °C for 24 h. 
1,2-Bis(10-Methyl-N-cytisinyl)ethane 12b
A Schlenk tube was charged with bromide 10 (175 mg, 0.31 mmol), PdCl2(PPh3)2 (22 mg, 0.10 eq) and it was placed under vacuum and backfilled with nitrogen for three times. The solids were dissolved in toluene (2 mL), tetrametyltin (0.22 mL, 5.0 eq) was added and the solution was heated at 100 °C for 24 h. The mixture was cooled, EtOAc (15 mL 
1,2-Bis(10-p-tolyl-N-cytisinyl)ethane 12c
A Schlenk tube was charged with 10 (282 mg, 0.50 mmol), PdCl2(PPh3)2 (35 mg, 50 μmol, 10 mol%), p-tolyl boronic acid (163 mg, 1.20 mmol) and K2CO3 (347 mg, 2.50 mmol). After purging with nitrogen, THF (5.0 mL) and water (1.2 mL) were added and the reaction mixture was heated at reflux for 23 h. The solution was cooled to r.t. and distributed between DCM(5 mL) and water (5.0 mL), and the aqueous phase was extracted with DCM (3 × 5 mL). The combined organic phases were dried (Na2SO4), filtered, and concentrated in vacuo. 
1,2-Bis(10-(N,N'-dimethylamino)-N-cytisinyl)ethane hydrochloride salt 12e
A sealed tube with screwed cap was charged with dibromide 10 (141 mg, 0.25 mmol), Pd(OAc)2 (6 mg, 25 μmol, 10 mol%), BINAP (21 mg, 35 μmol, 14 mol%) and NaOtBu (120 mg, 1.25 mmol). After purged with N2, toluene (1.7 mL) and dimethylamine (0.50 mL, 1 M in THF, 0.50 mmol) were added. The tube was sealed and the reaction mixture was stirred at 65 °C for 20 h. The solution was cooled to r.t. and distributed between water (10 mL) and DCM (10 mL), and the aqueous phase was extracted with DCM (4 × 10 mL). The combined organic phases were dried (Na2SO4), filtered, and concentrated in vacuo. 
1,2-Bis(10-morpholino-N-cytisinyl)ethane 12f
A Schlenk tube was charged with dibromide 10 (141 mg, 0.25 mmol), morpholine (87 μL, 1.00 mmol), Pd(OAc)2 (6 mg, 25 μmol, 10 mol%), BINAP (21 mg, 35 μmol, 14 mol%) and NaOtBu (120 mg, 1.25 mmol). After purged with N2, toluene (1.7 mL) was added and the reaction mixture was stirred at 100 °C for 21 h. The solution was distributed between water (10 mL) and DCM (10 mL), and the aqueous phase was extracted with DCM (4 × 10 mL). The combined organic phases were dried (Na2SO4), filtered, and concentrated in vacuo. [α]D 24 = -38 (c 1.0, MeOH). 
Diethyl 1,2-bis(N-(-)-cytisinyl)ethane-10-ethyl acrylate hydrochloride salt 12h
A Schlenk tube was charged with dibromide 10 (141 mg, 0.25 mmol) and Pd2(dba)3 (11 mg, 5 mol%), placed under vacuum and backfilled with nitrogen for three times. 1,4-dioxane (2.2 mL) was added, followed by tri--butylphosphine (0.25 mL, 0.1 M in 1,4-dioxane, 10 mol%), dicyclohexylmethylamine (0.12 mL, 0.55 mmol), and ethyl acrylate (0.11 mL, 1.00 mmol) respectively. The reaction mixture was stirred at room temperature for 24 h. Pd2(dba)3 (11 mg, 5 mol%), tri-tertbutylphosphine (0.25 mL, 0.1 M in 1,4-dioxane, 10 mol%) and ethyl acrylate (0.11 mL, 1.00 mmol) were added butylphosphine (0.25 mL, 0.1 M in 1,4-dioxane, 10 mol%) and ethyl acrylate (0.11 mL, 1.00 mmol) were added and the reaction mixture was stirred further for 24 h. 
1,2-Bis(10-hydroxy-N-cytisinyl)ethane hydrochloride salt 12i
A Schlenk tube was charged with CC4 7 (203 mg, 0.50 mmol), [Ir(cod)(OMe)]2 (6.6 mg, 0.02 eq), 4,4'-di-tert-butyl-2,2'-dipyridyl (5.4 mg, 0.04 eq) and bis(pinacolato)diboron (177 mg, 1.4 eq) and was placed under vacuum and backfilled with nitrogen for three times. THF (1.0 mL, 0.5 M) was added and the reaction mixture was heated at reflux for 20 h. After this time 1 H NMR showed essentially 100% conversion. The solution was allowed to reach r.t. and then cooled to 0 °C. A solution 2M NaOH (1.5 mL, 6 eq.) was added followed by the addition of H2O2 (1.0 mL, 30% w/w in water), the Schlenk tube was removed from the ice bath and the reaction mixture was stirred for 24 h. 
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General Experimental Details.
All reagents were purchase from commercial suppliers and used without further purification unless otherwise stated. Anhydrous solvents were obtained by distillation using standard procedures or by using the Anhydrous Engineering Ltd. double alumina and alumina-copper catalyzed drying columns.
Reactions requiring anhydrous conditions were run under an atmosphere of dry nitrogen;
glassware and needles were flamed-dried prior to use or placed in the oven (150 °C) for at least 2 h and allowed to cool either in a desiccator, under vacuum, or an atmosphere of nitrogen. Thin layer chromatography was performed using aluminium backed 60 F254 silica plates. Visualisation was achieved by UV fluorescence or a basic KMnO4 solution and heat.
Flash column chromatography was performed on silica gel (Aldrich 40-63 µm, 230-400 mesh).
Infrared spectra were recorded using a Perkin Elmer Spectrum One FT-IR Spectrometer as solids or neat films in the range of 600-4000 cm 2. Optimization studies for the Ir-catalyzed borylation of cytisine derivatives. 
